Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1981 1
1983 1
1984 1
1986 1
1989 1
1992 2
1993 1
1994 2
1995 5
1996 5
1997 6
1998 10
1999 6
2000 9
2001 13
2002 12
2003 9
2004 14
2005 4
2006 15
2007 15
2008 11
2009 17
2010 16
2011 19
2012 15
2013 13
2014 11
2015 22
2016 22
2017 35
2018 26
2019 17
2020 26
2021 28
2022 41
2023 33

Text availability

Article attribute

Article type

Publication date

Search Results

425 results

Results by year

Filters applied: . Clear all
Page 1
A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae.
George PM, Reed A, Desai SR, Devaraj A, Faiez TS, Laverty S, Kanwal A, Esneau C, Liu MKC, Kamal F, Man WD, Kaul S, Singh S, Lamb G, Faizi FK, Schuliga M, Read J, Burgoyne T, Pinto AL, Micallef J, Bauwens E, Candiracci J, Bougoussa M, Herzog M, Raman L, Ahmetaj-Shala B, Turville S, Aggarwal A, Farne HA, Dalla Pria A, Aswani AD, Patella F, Borek WE, Mitchell JA, Bartlett NW, Dokal A, Xu XN, Kelleher P, Shah A, Singanayagam A. George PM, et al. Among authors: micallef j. Sci Transl Med. 2022 Nov 16;14(671):eabo5795. doi: 10.1126/scitranslmed.abo5795. Epub 2022 Nov 16. Sci Transl Med. 2022. PMID: 36383686 Free article.
Prévention des risques liés à un usage inapproprié/consommation inutile des médicaments.
Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V. Cracowski JL, et al. Among authors: micallef j. Therapie. 2022 Jan-Feb;77(1):69-78. doi: 10.1016/j.therap.2021.12.020. Epub 2022 Jan 4. Therapie. 2022. PMID: 35067334 Free PMC article. French.
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Pariente A, Micallef J, Lahouegue A, Molimard M, Auffret M, Chouchana L, Denis B, Faillie JL, Grandvuillemin A, Letinier L, Pierron E, Pons C, Pujade I, Rubino H, Salvo F. Pariente A, et al. Among authors: micallef j. Therapie. 2023 Jan-Feb;78(1):115-129. doi: 10.1016/j.therap.2022.11.003. Epub 2022 Nov 25. Therapie. 2023. PMID: 36577617 French. No abstract available.
Quelles actions pour lutter contre la désinformation sur les produits de santé ?
Micallef J, Maisonneuve H, Muller S, Molimard M, Bégaud B, Cabut S, Daban M, Drici MD, Gatignol C, Grumblat A, Guaspare-Cartron C, Lasserre B, Mebarki A, Pons C, Prabonnaud F, Raynaud C, Saint-Lary O. Micallef J, et al. Therapie. 2023 Oct 29:S0040-5957(23)00154-3. doi: 10.1016/j.therap.2023.10.004. Online ahead of print. Therapie. 2023. PMID: 37985308 French. No abstract available.
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: micallef j. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
How to strengthen the presence of patients in health technology assessments conducted by the health authorities.
Mamzer MF, Dubois S, Saout C; participants of Round Table «Topical Subject» of Giens XXXIII; Albin N, Béhier JM, Buisson A, Diebolt V, Delaitre O, Duguet C, Fagon JY, Gaillard S, Le Jeunne C, Mazars R, Micallef J, Nabarette H, Piazza L, Raynaud C, Varoqueaux N. Mamzer MF, et al. Among authors: micallef j. Therapie. 2018 Feb;73(1):95-105. doi: 10.1016/j.therap.2017.11.004. Epub 2017 Dec 21. Therapie. 2018. PMID: 29478707 French.
Orphan drug clinical development.
Blin O, Lefebvre MN, Rascol O, Micallef J. Blin O, et al. Among authors: micallef j. Therapie. 2020 Apr;75(2):141-147. doi: 10.1016/j.therap.2020.02.004. Epub 2020 Feb 13. Therapie. 2020. PMID: 32247678 Review.
Propofol and infectious complications.
Micallef J, Pietri T. Micallef J, et al. Therapie. 2023 Jul-Aug;78(4):349-351. doi: 10.1016/j.therap.2022.10.007. Epub 2022 Oct 17. Therapie. 2023. PMID: 37105896 No abstract available.
Drugs and orphan diseases.
Blin O, Micallef J. Blin O, et al. Among authors: micallef j. Therapie. 2020 Apr;75(2):131-132. doi: 10.1016/j.therap.2020.02.002. Epub 2020 Feb 13. Therapie. 2020. PMID: 32247679 No abstract available.
425 results